Jerry Shu-Hung Kuo

2PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 24, 2025
Rebiopsy Enhances Survival with Afatinib vs. Osimertinib in EGFR Exon 19 Deletion Non-Small Cell Lung Cancer: A Multicenter Study in Taiwan.

Jerry Shu-Hung Kuo, Cheng-Yu Chang, Shih-Chieh Chang

Pageof 1